Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01338701 · ClinicalTrials.gov registry record · Phase 2
Exploratory Study to Evaluate 2 Acupuncture Methods for the Treatment of Headaches Associated With TBI
A Phase 2 study, sponsored by Samueli Institute for Information Biology.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01338701: Completed Phase 2 study, sponsored by Samueli Institute for Information Biology.
NCT01338701 is a Phase 2 study that has completed, run by Samueli Institute for Information Biology. The registered enrollment target is 45 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01338701, a Phase 2 study, has completed, sponsored by Samueli Institute for Information Biology.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study investigates whether acupuncture can help to decrease the number and severity of headaches in people who have Traumatic Brain Injury. The aim of this study is to compare two different types of acupuncture-either Traditional Chinese Acupuncture or ear acupuncture-to a group that receives no acupuncture at all. Acupuncture has been demonstrated to reduce pain, improve health-related quality of life, prevent migraine headaches, and improve tension and chronic daily headaches.
Primary Outcome
This is a 6-item measure that assesses headache severity. This will take approximately 1 minute to complete.
Interventions
- OTHER Usual Care
- PROCEDURE Traditional Chinese Acupuncture (TCA)
- PROCEDURE Auricular (Ear) Acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-04 |
| Phase | Phase 2 |
What the finished NCT01338701 record still lists
NCT01338701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT01338701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01338701 about?
NCT01338701 is a clinical study titled "Exploratory Study to Evaluate 2 Acupuncture Methods for the Treatment of Headaches Associated With TBI". This study investigates whether acupuncture can help to decrease the number and severity of headaches in people who have Traumatic Brain Injury. The aim of this study is to compare two different types of acupuncture-either Traditional Chinese Acupuncture or ear acupuncture-to a group that receives n...
What is the current status of trial NCT01338701?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2011-02. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01338701?
The interventions under investigation include: Usual Care (OTHER), Traditional Chinese Acupuncture (TCA) (PROCEDURE), Auricular (Ear) Acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT01338701?
This trial is sponsored by Samueli Institute for Information Biology, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01338701's enrollment target sits among peer trials
45 1296th of 2000 higher than 679 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia